Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   
OVERLAP
37%

OVERLAP
BY WEIGHT
14

# OF OVERLAPPING
HOLDINGS
CANC
53
HOLDINGS
27%
ALSO IN HRTS
HRTS
42
HOLDINGS
33%
ALSO IN CANC
SECTOR DRIFT (CANC minus HRTS)
OVERLAPPING HOLDINGS

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in HRTS
Overlap
ELI LILLY & CO 4.8% 11.5% 4.8%
ROCHE HOLDINGS LTD-SPONS ADR 4.2% 4.5% 4.2%
MERCK & CO. INC. 3.6% 4.3% 3.6%
ASTRAZENECA PLC 3.5% 4.0% 3.5%
NOVARTIS AG 4.1% 3.4% 3.4%
CANC Overweight Relative to HRTS
COGENT BIOSCIENCES INC 4.1%
IMMUNOME, INC. 3.9%
REVOLUTION MEDICINES, INC. 3.8%
CELCUITY INC. 3.6%
LEGEND BIOTECH CORPORATION SPONSORED 3.5%
NUVALENT, INC. CLASS A 3.4%
EXELIXIS INC 2.8%
CG ONCOLOGY, INC. 2.4%
GENMAB A/S SPONSORED ADR 2.4%
IDEAYA BIOSCIENCES, INC. 2.3%
CANC Underweight Relative to HRTS
ELI LILLY & CO -6.7%
UNITEDHEALTH GROUP INC -5.2%
NOVO NORDISK A/S-B -5.2%
THERMO FISHER SCIENTIFIC INC -4.0%
VERTEX PHARMACEUTICALS INC -2.9%
DANAHER CORP -2.7%
ABBOTT LABORATORIES -2.6%
CYTOKINETICS INC -2.5%
GILEAD SCIENCES INC -2.3%
TEVA PHARMACEUTICAL-SP ADR -2.1%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY